H. Spahn‐Langguth

P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression Levels

Pascale Anderle, Eva Niederer, Werner Rubas et al. · Journal of Pharmaceutical Sciences · 1998 · 228 citations

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug☆

Abeer Hanafy, H. Spahn‐Langguth, Guy Vergnault et al. · Advanced Drug Delivery Reviews · 2007 · 198 citations

Pharmaceutical Science, Pharmacokinetic Evaluation, Pharmacokinetic Modeling +10

P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

H. Spahn‐Langguth, A Radschuweit, Alper Okyar et al. · PubMed · 1998 · 108 citations

Pharmaceutical Science, Gastrointestinal Pharmacology, Glycobiology +17

Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model Compound

Peter Langguth, Abeer Hanafy, Dorothea Frenzel et al. · Drug Development and Industrial Pharmacy · 2005 · 94 citations

Pharmaceutical Science, Engineering, Biomedical Engineering +16

Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT?

Monika Ofer, Siegfried Wolffram, Annette Koggel et al. · European Journal of Pharmaceutical Sciences · 2005 · 83 citations

Medicinal Chemistry, Pharmacological Study, Biochemistry +7